Aging and cancer.

Debashish Misra, Pearl H Seo, Harvey Jay Cohen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A substantial increase in the number of elderly people in the populations of developed nations in the coming years has been projected. Persons 65 years and older are at significantly higher risk of developing cancer when compared to younger individuals. There is a resulting increase in cancer incidence as well as mortality in this advanced age group. It is important to know how changes in physiological reserve and functional status in elderly patients, polypharmacy issues, comorbidities, and other age-related problems can affect cancer prognosis and management. Elderly patients are not adequately represented in clinical trials, thus creating a relative lack of information related to specific issues about elderly cancer patients and their care. Nevertheless, there is a substantial amount of guidance available, and in this review we will address selected issues of importance when considering the approach to the older cancer patient.

Original languageEnglish
Pages (from-to)457-465
Number of pages9
JournalClinical advances in hematology & oncology : H&O
Volume2
Issue number7
StatePublished - Jul 1 2004
Externally publishedYes

Fingerprint

Neoplasms
Polypharmacy
Developed Countries
Comorbidity
Patient Care
Age Groups
Clinical Trials
Mortality
Incidence
Population

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Misra, D., Seo, P. H., & Cohen, H. J. (2004). Aging and cancer. Clinical advances in hematology & oncology : H&O, 2(7), 457-465.

Aging and cancer. / Misra, Debashish; Seo, Pearl H; Cohen, Harvey Jay.

In: Clinical advances in hematology & oncology : H&O, Vol. 2, No. 7, 01.07.2004, p. 457-465.

Research output: Contribution to journalArticle

Misra, D, Seo, PH & Cohen, HJ 2004, 'Aging and cancer.', Clinical advances in hematology & oncology : H&O, vol. 2, no. 7, pp. 457-465.
Misra, Debashish ; Seo, Pearl H ; Cohen, Harvey Jay. / Aging and cancer. In: Clinical advances in hematology & oncology : H&O. 2004 ; Vol. 2, No. 7. pp. 457-465.
@article{95d20bb95a99476dbae6b05c1ca21d1f,
title = "Aging and cancer.",
abstract = "A substantial increase in the number of elderly people in the populations of developed nations in the coming years has been projected. Persons 65 years and older are at significantly higher risk of developing cancer when compared to younger individuals. There is a resulting increase in cancer incidence as well as mortality in this advanced age group. It is important to know how changes in physiological reserve and functional status in elderly patients, polypharmacy issues, comorbidities, and other age-related problems can affect cancer prognosis and management. Elderly patients are not adequately represented in clinical trials, thus creating a relative lack of information related to specific issues about elderly cancer patients and their care. Nevertheless, there is a substantial amount of guidance available, and in this review we will address selected issues of importance when considering the approach to the older cancer patient.",
author = "Debashish Misra and Seo, {Pearl H} and Cohen, {Harvey Jay}",
year = "2004",
month = "7",
day = "1",
language = "English",
volume = "2",
pages = "457--465",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "7",

}

TY - JOUR

T1 - Aging and cancer.

AU - Misra, Debashish

AU - Seo, Pearl H

AU - Cohen, Harvey Jay

PY - 2004/7/1

Y1 - 2004/7/1

N2 - A substantial increase in the number of elderly people in the populations of developed nations in the coming years has been projected. Persons 65 years and older are at significantly higher risk of developing cancer when compared to younger individuals. There is a resulting increase in cancer incidence as well as mortality in this advanced age group. It is important to know how changes in physiological reserve and functional status in elderly patients, polypharmacy issues, comorbidities, and other age-related problems can affect cancer prognosis and management. Elderly patients are not adequately represented in clinical trials, thus creating a relative lack of information related to specific issues about elderly cancer patients and their care. Nevertheless, there is a substantial amount of guidance available, and in this review we will address selected issues of importance when considering the approach to the older cancer patient.

AB - A substantial increase in the number of elderly people in the populations of developed nations in the coming years has been projected. Persons 65 years and older are at significantly higher risk of developing cancer when compared to younger individuals. There is a resulting increase in cancer incidence as well as mortality in this advanced age group. It is important to know how changes in physiological reserve and functional status in elderly patients, polypharmacy issues, comorbidities, and other age-related problems can affect cancer prognosis and management. Elderly patients are not adequately represented in clinical trials, thus creating a relative lack of information related to specific issues about elderly cancer patients and their care. Nevertheless, there is a substantial amount of guidance available, and in this review we will address selected issues of importance when considering the approach to the older cancer patient.

UR - http://www.scopus.com/inward/record.url?scp=29444434188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29444434188&partnerID=8YFLogxK

M3 - Article

C2 - 16163222

AN - SCOPUS:29444434188

VL - 2

SP - 457

EP - 465

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 7

ER -